WO2010109434A3 - A medicinal antibacterial, antifungal and steroids cream comprising chitosan and a process to make it - Google Patents
A medicinal antibacterial, antifungal and steroids cream comprising chitosan and a process to make it Download PDFInfo
- Publication number
- WO2010109434A3 WO2010109434A3 PCT/IB2010/051306 IB2010051306W WO2010109434A3 WO 2010109434 A3 WO2010109434 A3 WO 2010109434A3 IB 2010051306 W IB2010051306 W IB 2010051306W WO 2010109434 A3 WO2010109434 A3 WO 2010109434A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- skin
- skin infections
- infections
- chitosan
- antifungal
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/351—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom not condensed with another ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Inorganic Chemistry (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
The present invention relates to a composition for treating bacterial skin infections, fungal skin infections & skin inflammation, along with skin rejuvenation. More particularly, the present invention relates to a pharmaceutical cream comprising a biopolymer, a corticosteroid, an antifungal and an antibacterial active ingredient. It discloses a composition for treating bacterial skin infections, fungal skin infections & skin inflammation, along with skin rejuvenation containing a) a biopolymer in the form of chitosan, b) a combination of active ingredients used in treating bacterial skin infections, fungal skin infections & skin inflammations, c) a cream base containing primary and secondary emulsifiers, waxy materials, co-solvents, acids, preservatives, buffering agents, anti oxidants, chelating agents, and humectants, and d) water. The active ingredients, namely chitosan, a corticosteroid, an antifungal agent and an antibacterial agent, are incorporated in cream base for use in treating bacterial skin infections, fungal skin infections and skin inflammation.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN713MU2009 | 2009-03-25 | ||
| IN713/MUM/2009 | 2009-03-25 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| WO2010109434A2 WO2010109434A2 (en) | 2010-09-30 |
| WO2010109434A3 true WO2010109434A3 (en) | 2010-11-18 |
Family
ID=42536305
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/IB2010/051306 Ceased WO2010109434A2 (en) | 2009-03-25 | 2010-03-25 | A medicinal antibacterial, antifungal and steroids cream and a process to make it |
Country Status (1)
| Country | Link |
|---|---|
| WO (1) | WO2010109434A2 (en) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2010119367A2 (en) * | 2009-04-13 | 2010-10-21 | Sulur Subramaniam Vanangamudi | A medicinal cream made using hydrocortisone acetate and a process to make the same |
| WO2010119387A2 (en) * | 2009-04-13 | 2010-10-21 | Sulur Subramaniam Vanangamudi | A medicinal cream made using miconazole nitrate, fluticasone propionate, and chitosan, and a process to make the same |
| EP2419098A2 (en) * | 2009-04-13 | 2012-02-22 | Vanangamudi, Sulur Subramaniam | A medicinal cream made using miconazole nitrate and chitosan, and a process to make the same |
| US20120028943A1 (en) * | 2009-04-13 | 2012-02-02 | Apex Laboratories Private Limited | Medicinal Cream Made Using Fluticasone Propionate And Chitosan And A Process To Make The Same |
| WO2010119365A2 (en) * | 2009-04-13 | 2010-10-21 | Sulur Subramaniam Vanangamudi | A medicinal cream made using clotrimazole and chitosan and a process to make the same |
| WO2012023079A1 (en) * | 2010-08-17 | 2012-02-23 | Sulur Subramaniam Vanangamudi | A medicinal fusidic acid cream made using sodium fusidate and incorporating a biopolymer, fluticasone propionate, oxiconazole nitrate and a process to make it |
| WO2012049543A1 (en) * | 2010-10-15 | 2012-04-19 | Sulur Subramaniam Vanangamudi | A medicinal fusidic acid cream made using sodium fusidate and incorporating a biopolymer and a corticosteroid, and a process to make it |
| WO2012049544A1 (en) * | 2010-10-15 | 2012-04-19 | Sulur Subramaniam Vanangamudi | A medicinal fusidic acid cream made using sodium fusidate and incorporating a biopolymer, a hydrocortisone acetate as a corticosteroid, and clotrimazole as an antifungal agent, and a process to make it |
| WO2012049542A1 (en) * | 2010-10-15 | 2012-04-19 | Sulur Subramaniam Vanangamudi | A medicinal fusidic acid cream made using sodium fusidate and incorporating a biopolymer, mometasone as a corticosteroid and clotrimazol as antifungal agent, and a process to make it |
| WO2012049541A1 (en) * | 2010-10-15 | 2012-04-19 | Sulur Subramaniam Vanangamudi | A medicinal fusidic acid cream made using sodium fusidate and incorporating a biopolymer and a corticosteroid, and a process to make it |
| US9078853B2 (en) | 2013-06-18 | 2015-07-14 | Cmpd Licensing, Llc | Dry pharmaceutical compositions for topical delivery of oral medications, nasal delivery and to treat ear disorders |
| US11737975B2 (en) | 2016-11-17 | 2023-08-29 | Cmpd Licensing, Llc | Compounded compositions and methods for treating pain |
| US10966946B2 (en) | 2016-11-17 | 2021-04-06 | Cmpd Licensing, Llc | Compounded compositions and methods for treating pain |
| US10525025B2 (en) | 2016-11-17 | 2020-01-07 | Cmpd Licensing, Llc | Compounded compositions and methods for treating pain |
| US11986448B2 (en) | 2016-11-17 | 2024-05-21 | Cmpd Licensing, Llc | Compounded compositions and methods for treating pain |
| US9999604B2 (en) | 2016-11-17 | 2018-06-19 | Cmpd Licensing, Llc | Compounded solutions of diclofenac and lidocaine and methods |
| HUE067704T2 (en) * | 2019-10-24 | 2024-11-28 | Vishagan Vanangamudi Sulur | Topical pharmaceutical composition for bacterial infections and wound healing |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4946870A (en) * | 1986-06-06 | 1990-08-07 | Union Carbide Chemicals And Plastics Company Inc. | Delivery systems for pharmaceutical or therapeutic actives |
| US20020146440A1 (en) * | 2001-04-09 | 2002-10-10 | Smith Sadie N. | Mult-purpose skin balm including skin balm for psoriasis |
| US20030206958A1 (en) * | 2000-12-22 | 2003-11-06 | Cattaneo Maurizio V. | Chitosan biopolymer for the topical delivery of active agents |
| WO2004058262A1 (en) * | 2002-12-31 | 2004-07-15 | Wockhardt Limited | Benzoquinolizine-2-carboxylic acid-containing compositions |
| MD2519F1 (en) * | 2003-04-25 | 2004-08-31 | Universal Farm S R L | Cream for treatment of cutaneous affections |
-
2010
- 2010-03-25 WO PCT/IB2010/051306 patent/WO2010109434A2/en not_active Ceased
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4946870A (en) * | 1986-06-06 | 1990-08-07 | Union Carbide Chemicals And Plastics Company Inc. | Delivery systems for pharmaceutical or therapeutic actives |
| US20030206958A1 (en) * | 2000-12-22 | 2003-11-06 | Cattaneo Maurizio V. | Chitosan biopolymer for the topical delivery of active agents |
| US20020146440A1 (en) * | 2001-04-09 | 2002-10-10 | Smith Sadie N. | Mult-purpose skin balm including skin balm for psoriasis |
| WO2004058262A1 (en) * | 2002-12-31 | 2004-07-15 | Wockhardt Limited | Benzoquinolizine-2-carboxylic acid-containing compositions |
| MD2519F1 (en) * | 2003-04-25 | 2004-08-31 | Universal Farm S R L | Cream for treatment of cutaneous affections |
Non-Patent Citations (2)
| Title |
|---|
| ANONYMOUS: "Sofradex-F Cream", 1 January 2005 (2005-01-01), XP002596037, Retrieved from the Internet <URL:http://www.encubeethicals.com/pro_sub_4_1.htm> [retrieved on 20100811] * |
| RAVI KUMAR M N V: "A review of chitin and chitosan applications", REACTIVE & FUNCTIONAL POLYMERS, vol. 46, no. 1, 1 November 2000 (2000-11-01), ELSEVIER SCIENCE PUBLISHERS BV, NL, pages 1 - 27, XP004224437, ISSN: 1381-5148, DOI: 10.1016/S1381-5148(00)00038-9 * |
Also Published As
| Publication number | Publication date |
|---|---|
| WO2010109434A2 (en) | 2010-09-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2010109434A3 (en) | A medicinal antibacterial, antifungal and steroids cream comprising chitosan and a process to make it | |
| WO2010119369A3 (en) | A medicinal cream made using silver sulphadiazine and chitosan and a process to make it | |
| WO2010119364A3 (en) | A medicinal cream made using neomycin sulphate, betamethasone valerate, and chitosan, and a process to make the same | |
| WO2010109425A3 (en) | A medicinal steroids cream and a process to make it | |
| WO2009063493A3 (en) | Topical pharmaceutical composition for the combination of fusidic acid and a corticosteroid | |
| WO2011156030A3 (en) | High oil-content emollient aerosol foam compositions | |
| MX354480B (en) | Foamable benzoyl peroxide compositions for topical administration. | |
| WO2010135656A3 (en) | Barrier film-forming compositions and methods of use | |
| MX2011012143A (en) | Compositions suitable for the topical treatment of fungal infections of the skin and nails. | |
| WO2009017369A3 (en) | Compositions for skin protection and improvement of skin diseases containing the dibenzo-p-dioxine derivatives | |
| WO2009061431A3 (en) | Compositions for the treatment and prevention of eyelid swelling comprising an osmotically active ingredient and a vasoconstrictor | |
| EP4552650A3 (en) | Methods and compositions for treatment of skin | |
| WO2010119366A3 (en) | A medicinal cream made using fluticasone propionate, and chitosan, and a process to make the same | |
| WO2005034883A3 (en) | A method of healing skin wounds in mammals and a composition therefor | |
| EP3937905A4 (en) | Rinse-off compositions and uses thereof for delivery of active agents | |
| WO2011049327A3 (en) | A skin external composition comprising a salt and sugar as active ingredients for preventing and treating vaginosis and the use thereof | |
| WO2017083266A8 (en) | Novel formulations | |
| EP4397375A3 (en) | Isoxazoline parasiticide formulations and methods for treating blepharitis | |
| WO2017037075A8 (en) | Composition containing echinacea extract and linoleic acid derivatives | |
| WO2008136034A3 (en) | Ophthalmic compositions for the treatment of ocular hypertension and glaucoma | |
| WO2010119367A3 (en) | A medicinal cream made using hydrocortisone acetate and a process to make the same | |
| WO2010122490A3 (en) | A medicinal anti diaper rash cream incorporating a biopolymer and a process to make it | |
| EP4225292A4 (en) | Truxillic acid monoester-derivatives as selective fabp5 inhibitors and pharmaceutical compositions and uses thereof | |
| WO2010119384A3 (en) | A medicinal cream made using mometasone furoate, and chitosan, and a process to make the same | |
| WO2009149150A3 (en) | Composition comprising liposome-entrapped doxorubicin and methods of administration |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 10716083 Country of ref document: EP Kind code of ref document: A2 |
|
| WWE | Wipo information: entry into national phase |
Ref document number: 12011501885 Country of ref document: PH |
|
| NENP | Non-entry into the national phase |
Ref country code: DE |
|
| 122 | Ep: pct application non-entry in european phase |
Ref document number: 10716083 Country of ref document: EP Kind code of ref document: A2 |